Medistep Healthcare debuted on the NSE at ₹53, reflecting a 23.3% premium over its issue price of ₹43. The IPO bidding ran from August 8 to August 12, 2025, with allotment finalized on August 13, 2025.
Also Read: Penny stock hits 10% upper circuit after it reports strong Q1 results in FY26
Medistep Healthcare IPO details
Medistep Healthcare IPO witnessed overwhelming demand, subscribed 382.14 times overall by August 12, 2025, with retail investors bidding 461.11 times, non-institutional investors 289.15 times, while QIB subscription details (excluding anchor investors) remain undisclosed.
About Medistep Healthcare Ltd
Medistep Healthcare Ltd., incorporated in June 2023, is a pharmaceutical company offering sanitary pads, energy powders, pharmaceuticals, nutraceuticals, intimate care, and surgical products, focusing on quality, health, and expanding its diverse healthcare product portfolio.
Also Read: Wind energy stock jumps after its net profit increases by 134% YoY
Medistep Healthcare IPO objective
The objective of Medistep Healthcare IPO is to raise ₹16.10 crores through a fresh issue of 0.37 crore shares, aimed at funding business expansion, meeting working capital needs, and supporting general corporate purposes.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
FAQs
A: Medistep Healthcare listed at ₹53 per share, a 23.3% premium over its issue price of ₹43.
A: The IPO was subscribed 382.14 times overall, with retail investors bidding 461.11 times, QIBs 0 times (Ex-anchor), and NIIs 289.15 times.
A: The IPO aims to raise ₹16.10 crore through a fresh issue of 0.37 crore shares to fund expansion and working capital requirements.


